The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance
Open accessAbstract
Hypervirulent Klebsiella pneumoniae (hvKP) is traditionally defined by hypermucoviscosity, but data based on genetic background are limited. Antimicrobial-resistant hvKP has been increasingly reported but has not yet been systematically studied. K. pneumoniae isolates from bloodstream infections, hospital-acquired pneumonia, and intra-abdominal infections were collected from 10 cities in China during February to July 2013. Clinical data were collected from medical records. All K. pneumoniae isolates were investigated by antimicrobial susceptibility testing, string test, extended-spectrum β-lactamase (ESBL) gene detection, capsular serotypes, virulence gene profiles, and multilocus sequence typing. hvKP was defined by aerobactin detection. Of 230 K. pneumoniae isolates, 37.8% were hvKP. The prevalence of hvKP varied among different cities, with the highest rate in Wuhan (73.9%) and the lowest in Zhejiang (8.3%). Hypermucoviscosity and the presence of K1, K2, K20, and rmpA genes were strongly associated with hvKP ( P < 0.001). A significantly higher incidence of liver abscess ( P = 0.026), sepsis ( P = 0.038), and invasive infections ( P = 0.043) was caused by hvKP. Cancer (odds ratio [OR], 2.285) and diabetes mellitus (OR, 2.256) appeared to be independent variables associated with hvKP infections by multivariate analysis. Importantly, 12.6% of hvKP isolates produced ESBLs, and most of them carried bla CTX-M genes. Patients with neutropenia (37.5% versus 5.6%; P = 0.020), history of systemic steroid therapy (37.5% versus 5.6%; P = 0.020), and combination therapy (62.5% versus 16.7%; P = 0.009) were more likely to be infected with ESBL-producing hvKP. The prevalence of hvKP is high in China and has a varied geographic distribution. ESBL-producing hvKP is emerging, suggesting an urgent need to enhance clinical awareness, especially for immunocompromised patients receiving combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Holt, K. E., Wertheim, H., Zadoks, R. N., Baker, S., Whitehouse, C. A., Dance, D., Jenney, A., Connor, T. R., Hsu, L. Y., Severin, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501049112 · Cited by 1,236
Hypervirulent (hypermucoviscous)Klebsiella pneumoniae: A new and dangerous breed
Shon, A. S., Bajwa, R. P. S., & Russo, T. A. (2013) · Virulence · doi:10.4161/viru.22718 · Cited by 1,171
Fang, C.-T., Lai, S.-Y., Yi, W.-C., Hsueh, P.-R., Liu, K.-L., & Chang, S.-C. (2007) · Clinical Infectious Diseases · doi:10.1086/519262 · Cited by 649
Genomic Definition of Hypervirulent and Multidrug-Resistant Klebsiella pneumoniae Clonal Groups
Bialek-Davenet, S., Criscuolo, A., Ailloud, F., Passet, V., Jones, L., Delannoy-Vieillard, A.-S., Garin, B., Le Hello, S., Arlet, G., Nicolas-Chanoine, M.-H., et al. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140206 · Cited by 481
Mapping the Evolution of Hypervirulent Klebsiella pneumoniae
Struve, C., Roe, C. C., Stegger, M., Stahlhut, S. G., Hansen, D. S., Engelthaler, D. M., Andersen, P. S., Driebe, E. M., Keim, P., & Krogfelt, K. A. (2015) · mBio · doi:10.1128/mbio.00630-15 · Cited by 368
Russo, T. A., Olson, R., MacDonald, U., Beanan, J., & Davidson, B. A. (2015) · Infection and Immunity · doi:10.1128/iai.00430-15 · Cited by 305 · cited 1×
“Recently, aerobactin was considered a defining genetic trait and potential antivirulence target for hvKP (24).”
BackgroundLi, W., Sun, G., Yu, Y., Li, N., Chen, M., Jin, R., Jiao, Y., & Wu, H. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit675 · Cited by 304
Russo, T. A., Olson, R., MacDonald, U., Metzger, D., Maltese, L. M., Drake, E. J., & Gulick, A. M. (2014) · Infection and Immunity · doi:10.1128/iai.01667-13 · Cited by 304
Compain, F., Babosan, A., Brisse, S., Genel, N., Audo, J., Ailloud, F., Kassis-Chikhani, N., Arlet, G., & Decré, D. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02316-14 · Cited by 282
Nassif, X., & Sansonetti, P. J. (1986) · Infection and Immunity · doi:10.1128/iai.54.3.603-608.1986 · Cited by 277
Pomakova, D. K., Hsiao, C.-B., Beanan, J. M., Olson, R., MacDonald, U., Keynan, Y., & Russo, T. A. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1396-6 · Cited by 243
Zhang, Y., Zeng, J., Liu, W., Zhao, F., Hu, Z., Zhao, C., Wang, Q., Wang, X., Chen, H., Li, H., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.07.010 · Cited by 233
Self-citationLewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 231
Siu, L. K., Fung, C.-P., Chang, F.-Y., Lee, N., Yeh, K.-M., Koh, T. H., & Ip, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00977-11 · Cited by 230
Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae Strains in China
Zhang, R., Lin, D., Chan, E. W.-C., Gu, D., Chen, G.-X., & Chen, S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02173-15 · Cited by 229
Andrade, L. N., Curiao, T., Ferreira, J. C., Longo, J. M., Clímaco, E. C., Martinez, R., Bellissimo-Rodrigues, F., Basile-Filho, A., Evaristo, M. A., Del Peloso, P. F., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01783-10 · Cited by 194
Decré, D., Verdet, C., Emirian, A., Le Gourrierec, T., Petit, J.-C., Offenstadt, G., Maury, E., Brisse, S., & Arlet, G. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00676-11 · Cited by 183
Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae
Hennequin, C., & Robin, F. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2559-7 · Cited by 151
Lin, Y.-C., Lu, M., Tang, H., et al. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-50 · Cited by 138
Cheng, N., Yu, Y., Tai, H., Hsueh, P., Chang, S., Lai, S. T., Yi, W., & Fang, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis565 · Cited by 132
Su, S., Siu, L.-K. K., Ma, L., Yeh, K., Fung, C., Lin, J., & Chang, F. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01269-07 · Cited by 59
Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae
Siu, L.-K. K., Huang, D. B., & Chiang, T. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-176 · Cited by 51
Alcántar-Curiel, M. D., & Girón, J. A. (2015) · Virulence · doi:10.1080/21505594.2015.1030101 · Cited by 35
Liu, Y., Li, X., Wan, L., Jiang, W.-Y., Yang, J.-H., & Li, F.-Q. (2013) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0107 · Cited by 26
Cited by
Hypervirulent Klebsiella pneumoniae
Russo, T. A., & Marr, C. M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-19 · Cited by 1,311
Population genomics of Klebsiella pneumoniae
Wyres, K. L., Lam, M. M. C., & Holt, K. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0315-1 · Cited by 1,160
Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae
Martin, R. M., & Bachman, M. A. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00004 · Cited by 1,058
Hypervirulent Klebsiella pneumoniae – clinical and molecular perspectives
Choby, J. E., Howard‐Anderson, J., & Weiss, D. S. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13007 · Cited by 712
Klebsiella pneumoniae infection biology: living to counteract host defences
Bengoechea, J. A., & Sa Pessoa, J. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy043 · Cited by 568
Metadata
- Authors
- Zhang, Y., Zhao, C., Wang, Q., Wang, X., Chen, H., Li, H., Zhang, F., Li, S., Wang, R., & Wang, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2016-10
- Volume
- 60
- Issue
- 10
- Pages
- 6115-6120
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2500996975
- Cited by
- 333
- References
- 25
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.